BMN 165 (rAvPAL-PEG)
165-205
Phase 2 mab completed
Quick answer
BMN 165 (rAvPAL-PEG) for Phenylketonuria is a Phase 2 program (mab) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOMARIN PHARMACEUTICAL INC
- Indication
- Phenylketonuria
- Phase
- Phase 2
- Modality
- mab
- Status
- completed